Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- NuVasive Hitting 2008 Lows
Nov 19, 2008 12:10 PM
- 1 Stock Mutual Fund is Positive In America... Was Positive
Nov 14, 2008 10:06 AM
- Wyeth (NYSE:WYE) : Added to Conviction Buy List at Goldman Sachs
Nov 12, 2008 12:50 PM
- Rigel Pharmaceuticals– Crisis Or Opportunity?
Nov 10, 2008 09:57 AM
- November 5, 2008: Clean Up When Funds Clear Out
Nov 05, 2008 05:55 PM
- Wyeth Trades at Fair Value - Analyst Blog
Oct 23, 2008 11:23 AM
- Earnings Review: WB, WLP, WYE, MCD, NWA
Oct 22, 2008 12:31 PM
- Charles River And Shanghai BioExplorer Open CRO Facility
Oct 15, 2008 01:27 PM
- UK Limits Quality of Life Drugs To £30,000 Per Year
Oct 11, 2008 09:15 PM
- Analyst Comments: Unilever, Eagle Test, UST, Cache , China Southern, Du Pont, Advanced Auto, Wyeth
Sep 26, 2008 08:52 AM
- EDITORIAL: Now is the Time to Show Your Thanks
Nov 23, 2008 10:12 AM
- Job Cuts Felt at Home
Nov 22, 2008 08:56 PM
- Retailers Hold Steady
Nov 21, 2008 10:57 AM
- Jobless claims jump unexpectedly to 16-year high
Nov 20, 2008 01:58 PM
- Jobless claims jump unexpectedly to 16-year high
Nov 20, 2008 11:02 AM
- Fears Drive Down New Jersey Stocks
Nov 16, 2008 01:12 PM
- Circuit City Files for Bankruptcy / Henrico-Based Chain Borrows $1.1 Billion to Continue Operating
Nov 11, 2008 02:56 PM
- N.J. Stocks Enjoy a Bounce Back
Nov 01, 2008 05:13 PM
- Loop of Faith
Nov 01, 2008 04:02 AM
- Pharma Sales to Grow 1% to 2% in '09
Oct 30, 2008 05:56 AM
- Wyeth and Progenics Announce Positive Outcome of Phase 3 Clinical Study of Subcutaneous RELISTOR for Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain
Nov 26, 2008 08:07 AM
- CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
Nov 21, 2008 08:31 AM
- Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
Nov 20, 2008 05:20 PM
- Wyeth Declares Preferred Stock Dividend
Nov 20, 2008 04:42 PM
- MattsonJack Study Reveals Cachexia Emerging As a Lucrative Opportunity for Pharma Companies
Nov 20, 2008 11:03 AM
- Standard & Poor's Announces Changes to U.S. Indices
Nov 17, 2008 06:45 PM
- Best Practice Database Shares Best Practices in Biopharma Public Relations
Nov 13, 2008 04:00 PM
- FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse
Nov 13, 2008 02:07 PM
- FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse
Nov 13, 2008 10:02 AM
- Intellect Neurosciences, Inc. Validates Pivotal European Patent for Alzheimer's Monoclonal Antibody Platform
Nov 11, 2008 06:10 AM
- Form 4 Germano Geno J For: Nov 25 (10K)
Nov 26, 2008 04:24 PM
- Form 3 Kamarck Michael E. For: Nov 20 (10K)
Nov 26, 2008 04:20 PM
- Form 4 GANZI VICTOR F For: Oct 20 (10K)
Oct 22, 2008 01:34 PM
- Form 4 AMEN ROBERT M For: Oct 20 (10K)
Oct 22, 2008 01:31 PM
- Form 3/A WYETH For: Apr 24 Filed by: CRITELLI MICHAEL J (10K)
Oct 03, 2008 07:18 PM
- Form 4 WYETH For: Oct 01 Filed by: ROGERS GARY L (10K)
Oct 02, 2008 04:31 PM
- Form 4 GANZI VICTOR F For: Jul 21 (10K)
Jul 23, 2008 06:34 PM
- Form 4 AMEN ROBERT M For: Jul 21 (10K)
Jul 23, 2008 06:28 PM
- Form 4 WYETH For: Jun 16 Filed by: Dolsten Mikael (10K)
Jun 18, 2008 05:15 PM
- Form 3 WYETH For: Jun 16 Filed by: Dolsten Mikael (10K)
Jun 18, 2008 05:14 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
WYE
|
Compare to S&P
|
| YTD |
-18.51 %
|
33.51 %
|
| 4 Weeks |
11.90 %
|
20.95 %
|
| 12 Weeks |
-11.76 %
|
22.31 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -1.10 %
|
|
EPS Growth in Last Year: 0.00 %
|
|
Sales Growth in Last Quarter: -1.95 %
|
|
Sales Growth in Last Quarter: 3.74 %
|
|
|
